immunotherapy Archives - Express Pharma

Bladder cancer diagnosed incident cases across 8MM to reach 0.34 mn in 2033

Merck’s colorectal cancer therapy fails late-stage trial

AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023

DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma

Israeli researchers develop bio-sensing technology to predict cancer treatment response

Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData

NIH study advances personalised immunotherapy for metastatic breast cancer

2021 is a key year for personalised neoantigen immuno-oncology therapeutics: GlobalData

ImmunityBio and NantKwest announce merger

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma